Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Subscribe

Title Date published
More basics on randomized controlled trials - Part 2 2023-03-02
RCT 101 And Papa Heme 2023-02-28
Tom Newman And VP Discuss Public Health 2023-02-22
5.41 - Michael Putman MCW debates me on recent policy Qs 2023-02-16
Sensible Med Superbowl Plenary Session Crossover 2023-02-13
5.39 - Sotorasib and Codebreak 200 2023-02-10
Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise 2023-01-22
5.37 - Keynote Lecture on Physician Burnout 2023-01-15
5.36 - ASH UPDATE #4 - GEM CESAR 2022-12-30
5.35 - ASH Update #3 - the Ascent Trial 2022-12-29
5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed 2022-12-24
5.33 USC Grand Rounds Hematology 2022-12-23
5.32 - ASH Update #1 - Talquetamab NEJM 2022-12-11
5.31 - MUST LISTEN Grand Rounds - COVID19 Updates 2022-12-08
5.30 Rajkumar vs Goodman; Long COVID vs Long URI 2022-12-03
5.29 Smart Start is a useless Lymphoma study 2022-11-27
5.28 - Pandemic Amnesty or Accountability with Paul Fenyves 2022-11-12
5.27 - Multiple Myeloma - Do Our Trials Help Patients? 2022-11-08
5.26 - Hawaii Oncology Association Keynote Lecture 2022-11-06
5.25 - Neurosurgery Grand Rounds by Vinay Prasad 2022-11-03
1234567891011121314151617181920

Comments about Plenary Session - inactive due to federal service

comments powered by Disqus
Advertisment: